Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
55M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
9.88M
-
Shares change
-
-168K
-
Total reported value, excl. options
-
$138M
-
Value change
-
-$15.9M
-
Number of buys
-
25
-
Number of sells
-
-33
-
Price
-
$13.96
Significant Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) as of Q3 2021
64 filings reported holding AKYA - Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q3 2021.
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.88M shares
of 55M outstanding shares and own 17.98% of the company stock.
Largest 10 shareholders include Board of Trustees of The Leland Stanford Junior University (2.24M shares), Hudson Executive Capital LP (1.85M shares), Polar Capital Holdings Plc (1.07M shares), BlackRock Inc. (410K shares), VR Adviser, LLC (400K shares), FMR LLC (394K shares), MILLENNIUM MANAGEMENT LLC (354K shares), VANGUARD GROUP INC (348K shares), WELLS FARGO & COMPANY/MN (347K shares), and AMERICAN CENTURY COMPANIES INC (305K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.